Wenjun Liao Selected Research

Wenjun Liao Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 04/2012
8	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2015
7	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2014
5	Nasopharyngeal Carcinoma 12/2023 - 01/2020
5	Melanoma (Melanoma, Malignant) 10/2020 - 03/2010
3	Carcinogenesis 04/2022 - 01/2014
2	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2021
2	Inflammation (Inflammations) 04/2022 - 08/2016
2	Pathologic Constriction (Stenosis) 01/2022 - 02/2017
2	Adenocarcinoma 01/2022 - 01/2014
1	Keratosis 04/2024
1	Klatskin Tumor 04/2024
1	Liver Failure 04/2024
1	Livedoid Vasculopathy 10/2023
1	Thrombosis (Thrombus) 10/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023
1	Lung Neoplasms (Lung Cancer) 09/2023
1	Primitive Neuroectodermal Tumors (PNET) 01/2023
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022
1	Adenocarcinoma of Lung 04/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2022
1	Myocardial Infarction 01/2022
1	Monilethrix 01/2022
1	Hemorrhage 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Hyperplasia 04/2019
1	Lithiasis 04/2019
1	Fatty Liver 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 11/2018
1	Choledocholithiasis 10/2018
1	Cholecystolithiasis 10/2018

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 04/2022 - 04/2014
3	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2017
3	Messenger RNA (mRNA)IBA 10/2022 - 04/2015
3	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2014
2	MicroRNAs (MicroRNA)IBA 10/2022 - 12/2018
2	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2016
2	Long Noncoding RNAIBA 01/2022 - 08/2017
2	Indicators and Reagents (Reagents)IBA 10/2020 - 01/2016
2	InterferonsIBA 12/2018 - 08/2018
2	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 01/2018
2	CytokinesIBA 01/2017 - 08/2016
2	Cell-Free Nucleic AcidsIBA 06/2016 - 04/2015
1	upadacitinibIBA 04/2024
1	BismuthIBA 04/2024
1	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 12/2023
1	FibrinIBA 10/2023
1	Biotin (Vitamin H)FDA Link 09/2023
1	CurcuminIBA 09/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2023
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2023
1	molybdenum disulfideIBA 09/2023
1	cyclo(Arg-Pro) (CI 4)IBA 01/2023
1	KinesinsIBA 10/2022
1	Janus KinasesIBA 04/2022
1	Toll-Like Receptor 3IBA 01/2022
1	Keratins (Keratin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 04/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2021
1	N-methyladenosineIBA 01/2021
1	6-methyladenineIBA 01/2021
1	5-ethynyl-2'-deoxyuridineIBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	ribociclibIBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Circular RNAIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	CarbohydratesIBA 04/2019
1	AntigensIBA 04/2019
1	condensin complexes (condensin)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Gemcitabine FDA Link 11/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2018
1	p38 Mitogen-Activated Protein KinasesIBA 08/2018
1	Ubiquitin-Specific ProteasesIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Deubiquitinating EnzymesIBA 01/2018

Therapy/Procedure

7	Radiotherapy 01/2024 - 01/2019
5	Therapeutics 01/2024 - 08/2017
3	Drug Therapy (Chemotherapy) 09/2023 - 01/2020
2	Hepatectomy 04/2024 - 10/2017
2	Stents 01/2022 - 02/2017
2	Immunotherapy 01/2021 - 10/2020
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024
1	Re-Irradiation 10/2023
1	Photothermal Therapy 09/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2023
1	Duration of Therapy 01/2023
1	Cholecystectomy 01/2022
1	Perioperative Period 12/2021
1	Subcutaneous Injections 01/2021
1	Induction Chemotherapy 11/2018
1	Laparoscopic Cholecystectomy 10/2018
1	Investigational Therapies (Experimental Therapy) 01/2018